Skip to main content

New story in Health from Time: NYU Med School Will Graduate Students Early to Help New York Fight Coronavirus



As COVID-19 continues to slam New York City hospitals, New York University’s Grossman School of Medicine this week took the dramatic step of letting its graduating class depart early to join the response effort.

New York City has rapidly become a hotspot for COVID-19, with more than 15,000 of the world’s roughly 440,000 cases as of the morning of March 25. Doctors and nurses have been working around the clock to care for the surge of patients, canceling elective procedures and non-urgent appointments to free up bed space, protective supplies and staffing for acutely ill patients.

NYU’s action aims to add more physicians to the ranks.

“In response to the growing spread of COVID-19, and in response to Governor Cuomo’s directive to get more physicians into the health system more quickly, NYU Grossman School of Medicine and NYU have agreed to permit early graduation for its medical students,” an NYU spokesperson confirmed to TIME. The decision is subject to approval by the New York State Department of Education, Middle States and the Liaison Committee on Medical Education.

According to an email circulating on Twitter, the option is available to students in NYU’s class of 2020 who have met all graduation requirements and volunteer to work in the NYU hospital system’s internal or emergency medicine departments beginning in April.

NYU’s decision is just one example of COVID-19’s shakeup to medical education. “Match Day,” when graduating medical students learn where they will complete their residency training, is typically a ceremonious occasion, when classes gather to announce their matches. But this year, with most mass gatherings canceled due to the outbreak, Match Day was a remote affair for students like John Damianos, who learned by email, surrounded by family at home, that he will leave Dartmouth University’s Geisel School of Medicine to start an internal medicine residency at Yale University this summer.

“Many people are more excited about Match Day than even graduation,” Damianos says. “It was not the Match Day we expected, but we all understood the important need for canceling it.”

Now, Damianos and his colleagues are readying themselves to potentially enter the workforce earlier than expected, and under highly uncertain conditions. Dartmouth-Hitchcock Medical Center has leaned on medical students to carry out a number of support roles during the pandemic, and hospitals around the country have done likewise. Health care students in Minnesota’s Twin Cities, for example, have developed a childcare network for workers on the front lines.

Damianos, at least, says he’s ready to jump into patient care whenever the call comes.

“This is why I went into medicine: to help people, to serve as an advocate for public health,” he says. “This is it. This is the time to rise to the calling.”

Popular posts from this blog

New story in Health from Time: COVID-19 Has Been ‘Apocalyptic’ for Public Transit. Will Congress Offer More Help?

While trying to get to work over the past few months, Brittany Williams, a Seattle home care worker, has often been passed by two or three buses before one stops to let her board. Buses in her area that once carried anywhere from about 50 to 100 passengers have been limited to between 12 and 18 to prevent overcrowding in response to coronavirus, and Williams’ commute, typically a half-hour ride, now takes more than double that time. Other Seattle transit riders have described budgeting as much as an extra hour per trip to account for the reduced capacity, eating into their time at work, school or with family. Even with the ridership limits in place, Williams, 34, doesn’t feel safe on public transit. Some passengers don’t wear face coverings, and bus drivers sometimes ignore capacity limits, she says. On one ride with her seven-year-old son, she decided to get off at a stop far from her home after a driver allowed a crowd of people to board. “It’s very trying. I’ll put...

New story in Health from Time: A Montana Care Home Refused Free COVID-19 Tests. Now, Nearly Every Resident Has Coronavirus

(BILLINGS, Mont.) — It was meant to be a last line of defense to protect the most vulnerable as the coronavirus spread across the United States : Montana officials offered free testing in May for staff and residents at assisted living and long-term care facilities. But not all of them followed through, according to state data, including a facility in Billings, Montana’s largest city, that cares for people with dementia and other memory problems. The virus has infected almost every resident and killed eight, accounting for almost a quarter of Montana’s 34 confirmed deaths. Thirty-six employees also have tested positive at the facility where 59 people lived before the deaths began. Read more: ‘It’s Getting Worse.’ Nursing Home Workers Confront Risks in Facilities Devastated by Coronavirus While Montana’s rates of confirmed infections and deaths are much lower than other parts of the country, the outbreak at Canyon Creek Memory Care illustrates that even the most simple an...

New story in Health from Time: An At-Home Coronavirus Test May Be On the Way in the U.S.

As cases of COVID-19 continue to climb in the U.S. , there’s a new urgency to make sure there are as many tests as possible to diagnose people who have symptoms that might indicate an infection. Knowing if people are positive is important for guiding their next steps: self-isolation, avoiding contact with others, and, if their symptoms get worse, seeking medical care. To date, access to tests has been spotty at best across the country, and while more kits are now available than even a week ago , most are gene-based assays that take several days for commercial labs to process and produce results. That may change in about two months if the Food and Drug Administration (FDA) gives Emergency Use Authorization to the first blood-based COVID-19 test in the U.S. Scanwell Health, an at-home test company based in California, licensed the rights to a test developed by Chinese company Innovita, which was used extensively at the height of country’s epidemic earlier this year. “The ...